Introduction
============

Chikungunya virus (CHIKV) is an arthropod-borne virus classified under the arthritogenic group of *Alphavirus* genus from the *Togaviridae* family ([@ref-5]). CHIKV is primarily transmitted by female mosquitoes of the *Aedes* genus, namely *Aedes aegypti* and *Aedes albopictus*, though *Culex ethiopicus* and *Anopheles stephensi* have also been reported as potential vectors. Over the years, massive outbreaks have been recorded in Africa, India and Indian Ocean islands as well as South and South-East Asia ([@ref-7]; [@ref-23]; [@ref-27]). In addition to the spread of CHIKV by *Aedes albopictus* to America and Europe, return of high viraemia infected travellers, have caused concerns of CHIKV transmittance to new endemic regions ([@ref-4]; [@ref-69]). Within 2--4 days following the initial mosquito bite, CHIKV enters the bloodstream where it disseminates to its respective target organs for subsequent replication. Infected patients generally suffer from symptoms such as polythermia (\> 39 °C), maculopapular rashes, polyarthralgia, cephalgia and nauseas ([@ref-67]). Further complications involving the inflammation of heart muscles (myocarditis), brain and meninges (meningoencephalitis) as well as haemorrhage have also been reported but rare ([@ref-16]). Though CHIKV is a self-limiting viral infection, 30--40% of patients have been complaining of recurrent joint pains which may last from a few weeks up to several years following recovery ([@ref-36]).

This small, spherical and enveloped virus contains a single positive-strand RNA genome which is about 11.8 kb in size ([@ref-32]). The genome is made up of two open reading frames (ORFs), whereby the ORF covering 5′ two-thirds of the genome codes for the non-structural proteins, whereas CHIKV structural proteins are encoded by the 3′ ORF ([@ref-64]). Cleavage of the polyproteins results in five structural (C, E3, E2, 6K, E1) and four nonstructural (nsP1, nsP2, nsP3, nsP4) proteins, with distinct functions.

While the structural proteins are mainly involved in the early stages of CHIKV replication cycle comprising of the attachment and entry of virus particles into infected cells, CHIKV nonstructural proteins are vital for the intracellular replication of new virus particles. The nonstructural proteins originated from a polyprotein (P1234) which is directly translated from the 5′ two-thirds of CHIKV genomic RNA. The section between nsP3 and nsP4 in the precursor protein is then cleaved in *cis*, resulting in P123 and nsP4 proteins ([@ref-38]). Subsequently, an unstable replication complex made up of these proteins as well as cellular factors is assembled, which synthesizes minus-strand genomic RNA. Further cleavage of the P123 protein into nsP1 and P23, together with nsP4, gives rise to a replication complex within virus-induced cytopathic vacuoles (CPV I), capable of both the synthesis of sense and antisense genomic RNA ([@ref-20]; [@ref-56]; [@ref-60]). Following the complete processing into individual nsP1, nsP2, nsP3 and nsP4 proteins, a stable polymerase complex is formed capable of the production of the positive-sense genomic and subgenomic RNA molecules ([@ref-29]).

The nsP1 protein via its guanine-7-methyltransferase and guanylyl transferase activities, catalyses the capping and methylation of newly synthesized viral mRNA in addition to its role in the synthesis of viral antisense RNA molecules ([@ref-2]; [@ref-39]). NsP1 is also involved in the attachment of virus polymerase complex to cellular membranes through interactions between the negatively-charged phospholipids with the amphipathic binding peptide (BP), and is enhanced by nsP1 palmitoylation ([@ref-49]). Study has shown that alteration in the specific as well as the surrounding palmitoylation site reduces virus replication hence, its viability ([@ref-3]). The nsP2 is multifunctional whereby it possesses the N-terminal RNA triphosphatase domain which catalyses the capping of viral RNA as well as the protein's RNA helicase activity ([@ref-19]; [@ref-24]).

The C-terminal of the protein has cysteine protease activity which is essential for the autocatalysis of the P123 polyprotein, as well as a domain with methyltransferase-like activity of undiscovered function ([@ref-8]). It has also been reported that nsP2 regulates the transcription and translation of viral proteins using the host cell machinery besides protection against interferon's inhibitory activity ([@ref-18]). The nsP3 protein is made up of three domains, namely the evolutionarily highly conserved N-terminus, the centre domain unique only for *Alphaviruses* and the heavily phosphorylated C-terminus. Its macrodomain is suggested to mediate ADP-ribose 1″-phosphate and/or other ADP-ribose derivatives metabolism which regulate cellular activities ([@ref-59]). On the other hand, the Cterminus contains Src-homology 3 (SH3) binding motifs for the localization of cellular amphiphysins Amph1 and BIN1/Amph2 following virus infection which promote *Alphavirus* genome replication ([@ref-43]). NsP3 also mediates cellular stress response by blocking the assembly of stress granules via the interaction between its SH3 binding motifs with Ras-GAP SH3 domain-binding protein (G3BP) ([@ref-17]). On the other hand, CHIKV nsP4 functions as RNA-dependent RNA polymerase vital for the elongation of the newly synthesised viral RNA molecules ([@ref-52]). A study also demonstrated the close interactions between CHIKV nsP4 as well as nsP3 proteins with the heat shock protein, HSP-90 which has been shown to play an important role in the replication process of several DNA and RNA viruses ([@ref-51]).

Sphingosine kinases (SPKs) are lipid kinases involved in the conversion of sphingosine into sphingosine-1-phosphate (S1P). Two types of SPKs are present in mammalian cells, namely SPK1 and SPK2 which are translated from *SPHK1* gene on chromosome 17 and *SPHK2* gene on chromosome 19, respectively ([@ref-42]). Previous studies have shown close association between SPK/S1P pathway and important cellular processes such as cell growth, inflammation and immune responses, with both types of SPKs having the opposing effects ([@ref-34]; [@ref-45]; [@ref-46]; [@ref-63]). Interestingly, in addition to its contribution towards the development of degenerative diseases in humans, SPKs also play important roles in several viral infections, including Dengue and Influenza A viruses for SPK1 as well as Hepatitis C virus, Kaposi's sarcoma-associated herpes virus, and most importantly for our study, CHIKV for SPK2 ([@ref-10]; [@ref-13]; [@ref-14]; [@ref-53]; [@ref-57]; [@ref-70]).

Flavonoids are a group of polyphenolic plant compounds which are synthesised via the phenylpropanoid pathway. Over the years, different types of flavonoids have been the subject of research for their wide range of medicinal benefits--anti-oxidant, anti-tumour, anti-inflammation and anti-microbial activities ([@ref-37]; [@ref-48]; [@ref-50]; [@ref-58]). Indeed, various flavonoids have been reported for their antiviral properties against Dengue Virus (DENV), Herpes Simplex Virus (HSV), Human Cytomegalovirus (HCMV) and etc ([@ref-12]; [@ref-33]; [@ref-41]; [@ref-47]; [@ref-72]). In our previous study, we have found that hesperetin which belongs to the flavanone class of flavonoids possesses effective inhibitory effect on the in vitro intracellular replication of CHIKV ([@ref-74]). Hence, at present we will be performing an in silico investigation to identify the possible target proteins for subsequent mechanistic study of hesperetin on CHIKV.

Materials and Methods
=====================

Receptor and ligand preparation
-------------------------------

The receptors used in this study are the three-dimensional protein structures of CHIKV nsP1, nsP2, nsP3, nsP4 and the mammalian cells' SPK2. CHIKV nsP1 and nsP4 as well as the SPK2 protein structures were modelled using the Iterative Threading Assembly Refinement (I-TASSER) server based on the amino acid sequences obtained from Universal Protein Resource (UniProt) ([@ref-55]; [@ref-71]; [@ref-73]). On the other hand, nsP2 and nsP3 crystal structures were retrieved from the Protein Data Bank (PDB) with PDB IDs of 3TRK and 3GPG respectively. Using the Discovery Studio 2.5 software, water molecules were removed and CHARMM27 force field was applied onto these protein structures. Subequently, steric overlaps were removed and the structures were processed 1,000 steps using the smart-minimizer algorithm. Hesperetin was used as the ligand in this experiment, of which the ligand structure was generated using ChemDraw software (CambridgeSoft). The 2D-structure was then minimized using the Discovery Studio 2.5 software followed by the preparation of both the ligand and receptors during which hydrogen molecules were added using the AutoDock Vina 1.5.6 software, which were then saved as PDBQT files.

Molecular docking
-----------------

In our study, the binding properties of the ligand to each protein were analysed using the AutoDock Vina 1.5.6 software. Blind dockings were performed in which grid boxes of sizes sufficient to cover the entire receptors of interest were constructed according to the parameters as tabulated in [Table 1](#table-1){ref-type="table"}. All grid boxes were formed at spacing size of 1.000 Å. Following the docking procedure, the resulting PDBQT output file was first opened in the PyMOL software in which all protein conformations were converged in a single file for further analysis. Each conformation was then analysed using the AutoDock Vina 1.5.6 and Discovery Studio 2.5 software whereby information such as binding affinities, interaction energies, van der Waals energies, electrostatic energies, hydrogen bonding, pi-pi interactions, pi-cation interactions and close contacting residues were obtained and recorded. Separately, the Lipinski's values for hesperetin were determined using the Lipinski Filters (SCFBio, Delhi) ([@ref-22]; [@ref-30]).
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###### Parameters used for molecular docking of hesperetin with each protein of interest.

All grid boxes with spacing size of 1.000 Å have sufficient sizes to cover the entire protein structures during molecular docking.

![](peerj-04-2602-g009)

  Proteins   Center-X   Center-Y   Center-Z   Size-X   Size-Y   Size-Z
  ---------- ---------- ---------- ---------- -------- -------- --------
  Nsp1       8.490      −21.201    −6.330     96       78       70
  3TRK       11.569     24.420     21.707     52       76       56
  3GPG       8.490      −21.201    −21.201    96       78       70
  NsP4       76.026     77.432     77.204     78       84       58
  SPK2       67.704     77.970     71.232     72       72       68

Molecular dynamics simulations
------------------------------

The docked complexes of hesperetin to the non-structural proteins--3GPG and 3TRK which demonstrated favourable free energy of binding during molecular docking were used as starting structures for the molecular dynamics (MD) simulations. A total of 10 ns MD simulations were performed using AMBER 14 ([@ref-9]). Amber ff14SB force field ([@ref-35]) was used to describe the proteins, waters and counter-ions. Antechamber was used to determine GAFF atom types for hesperetin, following Amber standard protocol. Restrained ElectroStatic Potential (RESP) charges were employed for ligands ([@ref-6]). MD simulations were performed using constant pressure (P) and temperature (T), NPT ensemble, maintaining the P and T at 1.0 atm and 310 K, respectively, by means of anisotropic P scaling and Langevin dynamics. The periodic boundary conditions based on the particle mesh Ewald method with a non-bonded cutoff of 8 Å were used. The integration time step was set at 2 fs and the SHAKE algorithm was used to constrain bond lengths involving hydrogen atoms. The system simulated underwent two stages of minimization using steepest descent and conjugate gradient with different parts of the system gradually released in stages. Then, it was slowly heated from 0 to 310 K within 500 ps with restraints on the complex. After the heating stage, the system was equilibrated for 1 ns, followed by another 10 ns of a relaxed MD run. The complete system trajectory was collected every 2 ps for analysis. Trajectories analyses were performed using the CPPTRAJ modules ([@ref-54]) of AMBER 16. The relative binding free energy for the complex was evaluated using MM-GBSA approach as implemented in Amber, using MMPBSA.py module ([@ref-40]) in Amber 16. A total of 500 snapshots from the relax MD trajectories were included in the calculations.

Results
=======

In this study, hesperetin was screened for potential inhibitory activities against all four CHIKV's non-structural proteins, namely nsP1, nsP2, nsP3 and nsP4 in addition to SPK2 via the docking of the compound to each protein. [Figures 1A](#fig-1){ref-type="fig"}--[1E](#fig-1){ref-type="fig"} show the bindings of hesperetin with the highest binding affinities upon docking against the proteins of interest. As illustrated, hesperetin exhibits the strongest binding affinity against 3GPG (−8.5 kcal/mol), followed by nsP4 and SPK2 (−7.7 kcal/mol), nsP1 (−7.6 kcal/mol) and finally 3TRK (−6.9 kcal/mol). The total interaction energies between the ligand and proteins resulting from the electrostatic as well as the weaker van der Waals forces are as tabulated in [Table 2](#table-2){ref-type="table"}.

![The binding positions with the highest binding affinities of hesperetin (yellow ball and stick structure) when docked against different proteins (flat ribbon coloured from N-to-C terminal).\
(A) nsP1 with binding affinity of −7.6 kcal/mol, (B) 3TRK with binding affinity of −6.9 kcal/mol, (C) 3GPG with binding affinity of −8.5 kcal/mol, (D) nsP4 with binding affinity of −7.7 kcal/mol, (E) SPK2 with binding affinity of −7.7 kcal/mol.](peerj-04-2602-g001){#fig-1}
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###### Binding energies between hesperetin and different types of proteins.

The energies involved in each ligand-receptor interaction was analysed using the Discovery Studio 2.5.

![](peerj-04-2602-g010)

  Proteins   Electrostatic interaction energy (kcal/mol)   Van der Waals interaction energy (kcal/mol)   Interaction energy (kcal/mol)
  ---------- --------------------------------------------- --------------------------------------------- -------------------------------
  NsP1       16.785                                        −29.699                                       −12.914
  3TRK       −454.598                                      −83.186                                       −537.784
  3GPG       −405.273                                      −129.780                                      −535.053
  NsP4       −32.689                                       −28.904                                       −61.594
  SPK2       14.815                                        −27.477                                       −12.663

Besides looking into the binding affinities and energies involved in the interaction of hesperetin with all five proteins, we have also taken into record of the bonds formed between the ligand and the binding sites on each protein. For nsP1, hydrogen bonds observed between this ligand-receptor proteins interactions are recorded in [Table 3](#table-3){ref-type="table"}. Hesperetin exhibits pi-pi and pi-cation interactions with TYR185, PHE43 and ARG70, ARG252, LYS442, respectively ([Table 4](#table-4){ref-type="table"}). The Discovery Studio 2.5 shows close amino acid residues found in the binding pocket between hesperetin and nsP1, namely LEU15, ALA17, LEU18, GLN19, ALA21, TYR22, ASN39, ALA40, PHE43, ALA40, PRO68, ALA69, ARG70, ARG71 and ALA104 as displayed in [Fig. 2](#fig-2){ref-type="fig"}.
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###### Hydrogen bonding between hesperetin and CHIKV nsP1.

This table documents the residues involved in the hydrogen bond formation as well as the angle DHA and length of the hydrogen bonds as analysed using the Discovery Studio 2.5. The binding affinities as ranked by the AutoDock Vina 1.5.6 are recorded in the final column of the table.

![](peerj-04-2602-g011)

  Hydrogen bonds                          Angle DHA (°)   Distance (Å)   Binding affinity (kcal/mol)
  --------------------------------------- --------------- -------------- -----------------------------
  Hesperetin:UNK1:H2--nsP1:ASP310:OD1     167.07°         1.66709        −7.6
  nsP1:GLY311:HN--Hesperetin:UNK1:O19     159.57°         2.13746        
  nsP1:ARG365:HH21--Hesperetin:UNK1:O20   93.9791°        2.49524        
  nsP1:ARG365:HH22--Hesperetin:UNK1:O20   104.508°        2.33411        
  nsP1:ARG365:HH22--Hesperetin:UNK1:O21   121.423°        2.29742        
  Hesperetin:UNK1:H1--nsP1:HIS45:ND1      149.472°        2.28058        −7.5
  nsP1:GLY190:HN--Hesperetin:UNK1:O20     124.29°         2.43961        
  Hesperetin:UNK1:H1--nsP1:ASP36:OD2      125.798°        2.08242        −7.4
  Hesperetin:UNK1:H2--nsP1:PRO68:O        146.956°        2.24366        
  nsP1:ARG71:HH11--Hesperetin:UNK1:O20    158.052°        2.07172        
  Hesperetin:UNK1:H3--nsP1:GLU129:O       119.206°        2.47249        
  nsP1:LEU108:HN--Hesperetin:UNK1:O20     153.395°        2.33121        
  nsP1:LEU135:HN--Hesperetin:UNK1:O17     125.791°        2.08609        
  nsP1:ARG70:HN--Hesperetin:UNK1:O17      134.179°        2.09364        −7.3
  nsP1:ARG252:HH12--Hesperetin:UNK1:O20   171.884°        2.30037        
  Hesperetin:UNK1:H1--nsP1:ASP448:OD1     154.403°        1.82012        −7.2
  Hesperetin:UNK1:H3--nsP1:VAL475:O       159.829°        1.84851        
  Hesperetin:UNK1:H3--nsP1:SER44:OG       119.912°        2.48095        −6.9
  nsP1:ARG71:HH12--Hesperetin:UNK1:O20    126.228°        2.28728        

![2D diagram of interaction between hesperetin and nsP1.\
The diagram shows the ligand-receptor interactions and close amino acid residues found in the binding pocket.](peerj-04-2602-g002){#fig-2}
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###### Pi-interactions between hesperetin and respective proteins.

The residues involved and length of each pi-interaction as well as the types of pi-interactions formed were analysed using the Discovery Studio 2.5.

![](peerj-04-2602-g012)

  Protein                             Binding                           Distance (Å)   Interaction
  ----------------------------------- --------------------------------- -------------- -------------
  NsP1                                Hesperetin:UNK1--ARG70:NE         5.2141         Pi-cation
  Hesperetin:UNK1--nsP1:TYR185        6.18796                           Pi-pi          
  Hesperetin:UNK1--nsP1:ARG252:NE     6.85892                           Pi-cation      
  Hesperetin:UNK1--ARG252:NE          6.0649                            Pi-cation      
  Hesperetin:UNK1--nsP1:PHE43         6.334                             Pi-pi          
  Hesperetin:UNK1--nsP1:LYS442:NZ     5.9124                            Pi-cation      
  3TRK                                Hesperetin:UNK1--3TRK:TYR1079     4.72556        Pi-pi
  Hesperetin:UNK1--3TRK:TYR1079       5.65846                           Pi-pi          
  Hesperetin:UNK1--3TRK:TYR1177       4.36635                           Pi-pi          
  Hesperetin:UNK1--3TRK:PHE1225:HB2   2.74925                           Pi-sigma       
  3GPG                                Hesperetin: UNK1--3GPG:TRP148     5.10212        Pi-pi
  Hesperetin: UNK1--3GPG:TRP148       4.15778                           Pi-pi          
  Hesperetin:UNK1--3GPG:LYS118:NZ     3.86706                           Pi-cation      
  Hesperetin:UNK1--3GPG:GLY30:HA1     2.84749                           Pi-sigma       
  Hesperetin:UNK1--3GPG:VAL113:HB     2.9202                            Pi-sigma       
  Hesperetin:UNK1--3GPG:TYR63         4.02708                           Pi-pi          
  3GPG:TRP148--Hesperetin:UNK1        4.22731                           Pi-pi          
  3GPG:TRP148--Hesperetin:UNK1        4.05885                           Pi-pi          
  NsP4                                Hesperetin:UNK1--nsP4:ARG374:NE   5.53545        Pi-cation
  Hesperetin:UNK1--nsP4:ARG70:NE      5.3946                            Pi-cation      
  Hesperetin:UNK1--nsP4:ARG70:NE      6.64674                           Pi-cation      
  Hesperetin:UNK1--nsP4:ARG70:NE      5.65215                           Pi-cation      
  Hesperetin:UNK1--nsP4:ARG70:NE      5.28131                           Pi-cation      
  Hesperetin:UNK1--nsP4:TYR22         4.15499                           Pi-pi          
  Hesperetin:UNK1--nsP4:ARG70:NE      4.49028                           Pi-cation      
  Hesperetin:UNK1--nsP4:TYR185        6.16947                           Pi-pi          
  Hesperetin:UNK1--nsP4:ARG70:NE      5.20374                           Pi-cation      
  Heesperetin:UNK1--nsP4:ARG70:NE     4.51522                           Pi-cation      
  Hesperetin:UNK1--nsP4:ARG70:HD1     2.61933                           Pi-sigma       
  SPK2                                Hesperetin:UNK1--SPK2:TYR372      4.91884        Pi-pi
  SPK2:TYR372--Hesperetin:UNK1        4.34443                           Pi-pi          
  Hesperetin:UNK1--SPK2:ARG351:NE     6.2923                            Pi-cation      

CHIKV's nsP2 is an important protein for the initial stage of new viral RNA synthesis. In this study we carried out molecular docking of hesperetin on the cysteine protease domain of the virus nsP2, as denoted as 3TRK. The hydrogen bonds between hesperetin and 3TRK are as shown in [Table 5](#table-5){ref-type="table"}. Pi-effects are observed at tyrosine residues of TYR1079 and TYR1177 as well as the phenylalanine PHE1225 ([Table 4](#table-4){ref-type="table"}). In [Fig. 3](#fig-3){ref-type="fig"}, we have demonstrated the close residues of 3TRK with hesperetin at ALA1046, TYR1047, SER1048, TYR1079, ASN1082, LEU1206, GLN1241 and GLY1245.

![2D diagram of interaction between hesperetin and 3TRK.\
The diagram demonstrates the ligand-receptor interactions and close amino acid residues found in the binding pocket.](peerj-04-2602-g003){#fig-3}
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###### Hydrogen bonding between hesperetin and 3TRK.

This table documents the residues involved in the hydrogen bond formation as well as the angle DHA and length of the hydrogen bonds as analysed using the Discovery Studio 2.5. The binding affinities as ranked by the AutoDock Vina 1.5.6 are recorded in the final column of the table.

![](peerj-04-2602-g013)

  Hydrogen bonds                           Angle DHA (°)   Distance (Å)   Binding affinity (kcal/mol)
  ---------------------------------------- --------------- -------------- -----------------------------
  Hesperetin:UNK1:H3--3TRK:ASP1246:OD1     132.214         2.19274        −6.9
  3TRK:TRP1084:HE1--Hesperetin:UNK1:O18    140.389         2.20564        
  3TRK:TRP1084:HE1--Hesperetin:UNK1:O19    148.713         2.13609        
  Hesperetin:UNK1:H3--3TRK:Ser1048:OG      144.592         2.32087        −6.8
  Hesperetin:UNK1:H1--3TRK:GLN1241:O       93.425          2.48789        −6.6
  3TRK:ALA1180:HN--Hesperetin:UNK1:O20     136.259         2.09817        −6.5
  3TRK:LYS1091:HZ2--Hesperetin:UNK1:O18    134.881         2.44139        −6.4
  3TRK:ARG1267:HH12--Hesperetin:UNK1:O19   141.467         2.27262        
  3TRK:ARG1267:HH22--Hesperetin:UNK1:O19   149.413         2.06422        
  Hesperetin:UNK1:H1--3TRK:LEU1065:O       144.638         2.23416        
  3TRK:PHE1225:HN--Hesperetin:UNK1:O10     145.498         2.33505        −6.1
  3TRK:ASN1135:HN--Hesperetin:UNK1:O18     126.233         2.487381       
  3TRK:ASN1135:HN--Hesperetin:UNK1:O19     129.610         2.38619        

Another protein studied is the nsP3 protein as denoted 3GPG, which plays multiple roles in the virus life cycle. [Table 6](#table-6){ref-type="table"} documents the hydrogen bonds linking hesperetin and 3GPG obtained from our docking experiment. Interestingly, we also observed pi-pi interactions with TRP148 and TYR63, pi-cation interaction with LYS118 as well as pi-sigma with GLY30 and VAL113 ([Table 4](#table-4){ref-type="table"}). Amino acid residues ALA22, ALA23, ASN24, ASP31, GLY32, VAL33, CYS34, PRO107, LEU109, THR111, GLY112, VAL113, TYR114, CYS143, ARG144 and ASP145 were also found closely in the binding pocket with hesperetin ([Fig. 4](#fig-4){ref-type="fig"}).

![2D diagram of interaction between hesperetin and 3GPG.\
The diagram illustrates the ligand-receptor interactions and close amino acid residues found within the binding pocket.](peerj-04-2602-g004){#fig-4}

We studied the potential inhibitory activity of hesperetin against CHIKV's nsP4 which serve as the polymerase for the elongation of newly synthesised RNA strands by simulating the docking process of the compound against this protein. In addition to the hydrogen bonds as shown in [Table 7](#table-7){ref-type="table"}, most pi interactions formed in this ligand-protein pair are pi-cations at ARG374 and ARG70 ([Table 4](#table-4){ref-type="table"}). The remaining pi-pi interactions formed at TYR22 and TYR185, whereas pi-sigma interaction was observed at ARG70 ([Table 4](#table-4){ref-type="table"}). Illustrated in [Fig. 5](#fig-5){ref-type="fig"} are the close residues including TRP199, ALA200, LEU313, CYS315, LYS316, Val321, VAL326, PHE328, ASN363, ILE366, THR372, GLN373.
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###### Hydrogen bonding between hesperetin and 3GPG.

This table documents the residues involved in the hydrogen bond formation as well as the angle DHA and length of the hydrogen bonds as analysed using the Discovery Studio 2.5. The binding affinities as ranked by the AutoDock Vina 1.5.6 are recorded in the final column of the table.

![](peerj-04-2602-g014)

  Hydrogen bonds                          Angle DHA (°)   Distance (Å)   Binding affinity (kcal/mol)
  --------------------------------------- --------------- -------------- -----------------------------
  Hesperetin:UNK1:H1--3GPG:TYR142:O       123.476         1.97816        −8.5
  3GPG:LEU108:HN--Hesperetin:UNK1:O17     162.843         2.17416        
  3GPG:SER110:HN--Hesperetin:UNK1:O20     145.746         2.0736         
  3GPG:VAL33:HN--Hesperetin:UNK1:O20      125.205         2.35031        −8.3
  3GPG:ARG144:HN--Hesperetin:UNK1:O19     159.099         1.95421        
  Hesperetin:UNK1:H2--3GPG:GLU17:O        165.815         1.93615        −7.3
  3GPG:THR122:HN--Hesperetin:UNK1:O       145.209         2.13631        
  3GPG:ASN72:HD22--Hesperetin:UNK1:O20    139.167         2.03974        
  3GPG:SER110:HN--Hepseretin:UNK1:O21     152.590         1.95709        −7.0
  3GPG:TRP41:HE1--Hesperetin:UNK1:O18     123.985         2.27795        
  3GPG:LYS7:HZ2--Hesperetin:UNK1:O20      144.885         2.15643        
  Hesperetin:UNK1:H3--3GPG:TYR4:O         148.477         2.16364        −6.9
  3GPG:GLN157:HE22--Hesperetin:UNK1:O20   129.097         2.30335        
  Hesperetin:UNK1:H1--3GPG:GLY116:O       128.866         2.03758        
  Hesperetin:UNK1:H2--3GPG:GLU17:OE2      128.230         2.31651        
  3GPG:ARG120:HH21--Hesperetin:UNK1:O17   123.759         2.34233        
  3GPG:LEU108:HN--Hesperetin:UNK1:O17     178.542         1.72039        

![2D diagram of interaction between hesperetin and nsP4.\
The diagram shows the ligand-receptor interactions and close amino acid residues found in the binding pocket.](peerj-04-2602-g005){#fig-5}

In addition to the virus proteins, we have also docked our compound of interest to cellular factor vital for virus replication such as SPK2. Our work shows hydrogen bonds between hesperetin and SPK2 as tabulated in [Table 8](#table-8){ref-type="table"}. TYR372 and ARG351 interact with the ligand via pi-pi and pi-cation bonding respectively ([Table 4](#table-4){ref-type="table"}). The hesperetin-SPK2 interaction also saw amino acid residues such as HIS251, ASN255, ASP259, CYS329, LEU425, PRO426, LEU427, PRO428, LEU432, ALA433, GLU624, GLN625, VAL626, GLU627 and TYR628 in close vicinities within the binding pocket ([Fig. 6](#fig-6){ref-type="fig"}).

10.7717/peerj.2602/table-7

###### Hydrogen bonding between hesperetin and CHIKV nsP4.

This table documents the residues involved in the hydrogen bond formation as well as the angle DHA and length of the hydrogen bonds as analysed using the Discovery Studio 2.5. The binding affinities as ranked by the AutoDock Vina 1.5.6 are recorded in the final column of the table.

![](peerj-04-2602-g015)

  Hydrogen bonds                          Angle DHA (°)   Distance (Å)   Binding affinity (kcal/mol)
  --------------------------------------- --------------- -------------- -----------------------------
  nsP4:GLN364:HE22--Hesperetin:UNK1:O21   148.552         2.20397        −7.7
  nsP4:ARG374:HH21--Hesperetin:UNK1:O19   121.976         2.4414         
  Hesperetin:UNK1:H3--nsP4:ALA104:O       127.732         2.19555        −7.6
  Hesperetin:UNK1:H1--nsP4:ALA103:O       147.014         1.88423        −7.5
  nsP4:GLY190:HN--Hesperetin:UNK1:O20     123.296         2.41584        −7.4
  Hesperetin:UNK1:H2--nsP4:ARG110:O       117.610         2.16176        
  nsP4:LEU108:HN--Hesperetin:UNK1:O20     147.895         2.27281        
  nsP4:LEU135:HN--Hesperetin:UNK1:O17     126.767         2.09964        
  Hesperetin:UNK1:H1--nsP4:THR437:O       111.885         2.2692         
  Hesperetin:UNK1:H2--nsP4:ASP479:OD1     108.572         2.17349        
  nsP4:THR437:HN--Hesperetin:UNK1:O17     174.240         2.08043        
  nsP4:LEU180:HN--Hesperetin:UNK1:O19     117.866         2.47914        
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###### Hydrogen bonding between hesperetin and SPK2.

This table documents the residues involved in the hydrogen bond formation as well as the angle DHA and length of the hydrogen bonds as analysed using the Discovery Studio 2.5. The binding affinities as ranked by the AutoDock Vina 1.5.6 are recorded in the final column of the table.

![](peerj-04-2602-g016)

  Hydrogen bonds                         Angle DHA (°)   Distance (Å)   Binding affinity (kcal/mol)
  -------------------------------------- --------------- -------------- -----------------------------
  SPK2:ARG227:HE--Hesperetin:UNK1:O21    132.729         2.39668        −7.7
  Hesperetin:UNK1:H3--SPK2:ALA431:O      106.199         2.32194        
  SPK2:GLN223:HE--Hesperetin:UNK1:O19    111.042         2.45074        −7.6
  SPK2: GLN625:HN--Hesperetin:UNK1:O17   110.511         2.45589        
  Hesperetin:UNK1:H1--SPK2:GLU624:OE1    139.804         2.27908        
  Hesperetin:UNK1:H2--SPK2:ARG373:O      129.174         1.92199        
  Hesperetin:UNK1:H3--SPK2:ASP342:OD1    141.848         2.21488        
  SPK2:ARG227:HE--Hesperetin:UNK1:O21    130.540         2.3656         −7.5
  Hesperetin:UNK1:H2--SPK2:GLN625:O      130.888         1.94553        
  Hesperetin:UNK1:H3--SPK2:ALA431:O      105.734         2.29542        
  SPK2:ASP110:HN--Hesperetin:UNK1:O17    152.041         2.32426        −7.4
  Hesperetin:UNK1:H1--SPK2:CYS100:O      138.862         2.43301        
  Hesperetin:UNK1:H2--SPK2:ARG373:O      120.303         2.05193        −7.3
  Hesperetin:UNK1:H3--SPK2:ASP342:OD1    147.571         2.13992        
  SPK2:GLY248:HN--Hesperetin:UNK1:O19    134.859         2.21696        −7.1
  Hesperetin:UNK1:H1--SPK2:CYS276:O      89.142          2.41654        
  Hesperetin:UNK1:H1--SPK2:THR641:OG1    135.818         2.17768        −7.0

![2D diagram of interaction between hesperetin and SPK2.\
The diagram demonstrates the ligand-receptor interactions and close amino acid residues found in the binding pocket.](peerj-04-2602-g006){#fig-6}

In order to ensure that the designed hesperetin molecule used in this experiment possesses the necessary drug-like properties to be developed as a therapeutic option for CHIKV infections, the Lipinski's values of our compound were determined and compared with the available data in PubChem ([Table 9](#table-9){ref-type="table"}).
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###### Lipinski's values of the hesperetin molecule designed for this study and that of the available data from PubChem.

A compound with drug-likeness properties should possess molecular weight less than 500 g/mol, Log P less than 5, less than 5 H-bond donors, less than 10 H-bond acceptors and molar refractivity in the range of 40--130.

![](peerj-04-2602-g017)

  Criteria                   From the present study   Extracted from PubChem
  -------------------------- ------------------------ ------------------------
  Molecular weight (g/mol)   302.00                   302.28
  H-bond donors              3                        3
  H-bond acceptors           6                        6
  Log-P                      2.5                      2.4
  Molar refractivity         76.75                    76.93

Hesperetin was found to bind and remain in the binding site throughout the simulation (see [Movie S1](#supp-1){ref-type="supplementary-material"}). For both systems (3GPG and 3TRK), root mean square deviation (RMSD) computed using the backbone atoms of the complex with respect to the minimized starting structure was found to be less than 1.8 Å ([Fig. 7](#fig-7){ref-type="fig"}). This showed that the systems are well equilibrated and do not deviate greatly from their initial starting structure. The lowest energy structures of the complexes are shown in [Fig. 8](#fig-8){ref-type="fig"}. To explore the binding of hesperetin to 3GPG and 3TRK, the relative free energy of binding was computed from enthalpy contributions, using snapshots extracted from the trajectories, following the MM-GBSA approach ([@ref-26]; [@ref-65]). [Table 10](#table-10){ref-type="table"} lists the contributions to the binding free energy for the simulated complexes--favourable contributions to the binding arose from van der Waals interactions and the non-polar part of the solvation free energy, as opposed to unfavourable total electrostatic contributions (EEL + EGB). The favourable binding free energy of −28.18 and −17.46 kcal/mol were for 3GPG-hesperetin and 3TRK-hesperetin, respectively. The estimated binding free energy calculated is in agreement with the docking study.

![Time series of RMSD from the minimized starting structure calculated using the backbone atoms of the protein.\
RMSD computed with respect to the minimized starting structure is less than 1.8 Å, hence showing that the simulated systems are well equilibrated and do not deviate much from the initial starting structure.](peerj-04-2602-g007){#fig-7}

![Lowest energy structure of ligand-receptor complexes.\
(A) 3GPG and (B) 3TRK in complexed with hesperetin (shown in stick representation, only polar hydrogen is shown). Both complexes remained stable throughout the 10 ns simulations.](peerj-04-2602-g008){#fig-8}
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###### Relative binding free energies of complexes estimated using MM-GBSA.

![](peerj-04-2602-g018)

  Complex             EEL      vdW      EGB     ESURF   Δ*E*~binding~
  ------------------- -------- -------- ------- ------- ---------------
  3GPG + hesperetin   −10.26   −36.62   23.47   −4.76   −28.18
  3TRK + hesperetin   −4.13    −28.32   18.61   −3.61   −17.46

**Notes:**

The EEL and vdW represent the electrostatic and van der Waals contributions from MM, respectively. EGB stands for GB electrostatic contribution to the solvation free energy, and ESURF is the nonpolar contribution to the solvation free energy.

Δ*E*~binding~ (in kcal mol^−1^, binding energy neglecting the contribution of entropy) is the final estimated binding free energy calculated from the terms above.

Discussion
==========

Since the initial Tanzania outbreak in 1952 CHIKV epidemics have been recorded in several parts of the world with different climate systems. The spread of CHIKV to countries outside the tropical regions has been attributed to the single amino acid alteration from alanine to valine (A226V) in the E1 gene ([@ref-68]). To date, approved therapeutic options and vaccines for CHIKV infections are lacking, though cases of CHIKV infected patients are constantly on the rise globally. Mechanistic studies in the past have shown anti-CHIKV effect of several compounds as a result of their interactions with different viral proteins, hence inhibiting further CHIKV replication ([@ref-15]; [@ref-25]; [@ref-28]). Furthermore, computational approaches have been applied by researchers in identifying potential interactions between drug candidates with specific CHIKV proteins in an effort to discover a novel anti-Chikungunya treatment ([@ref-1]; [@ref-44]; [@ref-62]). In this study, we aim to investigate the potential inhibitory effects of hesperetin, a flavanone, on different CHIVK non-structural proteins in addition to one of the cellular factors vital for CHIKV replication, SPK2.

Our findings showed that hesperetin possesses interactions with all four CHIKV non-structural proteins as well as SPK2 at different binding affinities. This is consistent with the inhibitory efficacy of hesperetin during the virus intracellular replication observed during our previous in vitro screening ([@ref-74]). Hesperetin has the highest tendency to bind with 3GPG with the affinity of −8.5 kcal/mol, followed by both nsp4 and SPK2 at −7.7 kcal/mol, nsP1 with the binding strength of −7.6 kcal/mol and finally 3TRK bound at −6.9 kcal/mol. Hence, CHIKV's nsP3 or 3GPG has the highest potential to be the target protein for hesperetin's inhibitory activity on the virus intracellular replication, though other proteins under study should not be excluded of the possibilities. Interestingly, CHIKV nsP3 protein plays a vital role in the early stages of viral genome replication involving synthesis of viral negative-strand and subgenomic RNAs ([@ref-28]). Previous study has also found that mutations resulting in alteration of the protein's amphiphysin SH3 binding motif and downregulation of Amph2 expression have been found to diminish in vitro viral RNA replication ([@ref-43]). Inhibition of both the nsP3 and nsP4 proteins could also block CHIKV replication via the heat shock protein, HSP-90 pathway ([@ref-51]). Besides the virus polymerase nsP4 which also modulate host immune response towards CHIKV infections via the PKR-like ER resident kinase (PERK) pathway ([@ref-52]), the host factor SPK2 was also ranked second by the AutoDock Vina 1.5.6 based on their binding affinities. NsP3-mediated SPK2 re-localisation to a puncta in the cytoplasm following an infection suggested the involvement of SPK2 in CHIKV replication. Close association of SPK2 with host proteins for mRNA processing and gene expression further link SPK2 with CHIKV replication process ([@ref-53]). Our findings suggest that inhibitory effect of hesperetin could be contributed by both direct activity on the virus proteins as well as cellular factors vital for the virus replication.

We have also identified the different types of non-covalent bonds between the ligand and the receptor proteins, including the hydrogen bonds, pi-pi, pi-cation and pi-sigma interactions. Hydrogen bond is a dipole-dipole interaction involving the transfer of a proton from one molecule to the electronegative recipient atom on another molecule. Hydrogen bond varies in strength based on the distance of the hydrogen bond, whereby as described by Szatylowicz, hydrogen bonds are classified as strong, moderate and weak if they fall into the ranges of 1.2--1.5, 1.5--2.2 and \> 2.2 Å, respectively ([@ref-66]). None of the hydrogen bonds formed between hesperetin and all five proteins in this study fall under the strong category. Instead, hesperetin formed moderately strong hydrogen bonds with relatively strong binding affinities with ASP310, GLY311, ASP36, ARG71 and LEU135 of nsP1, TYR142, LEU108, SER110, ARG144, GLU17, THR122 and ASN72 of 3GPG, GLN364, ALA104, ALA103, ARG110, LEU135, ASP479 and THR437 of nsP4, and finally ARG373, GLN625 and ASP342 of SPK2. Though strong hydrogen bonds were also observed between hesperetin and 3TRK at ASP1246 and TRP1084, their binding affinities were the lowest relative to the other four proteins studied.

Another type of non-covalent interaction investigated in this experiment are the pi interactions, which involve the electron-rich pi-system with another pi-system, anion, cation or other molecules. Among all the pi-interactions investigated in this study, the pi-sigma bonds have the strongest binding strength due to the larger overlaps of its s-orbitals ([@ref-21]; [@ref-61]). From our findings, we observed four pi-sigma interactions between hesperetin and 3TRK at PHE1225, 3GPG at GLY30 and VAL113 as well as ARG70 of nsP4. We have also documented the strong electrostatic forces between a polarised ligand and a receptor's binding site, as well as the van der Waals interaction energies. Van der Waals interactions, which are generally weaker as compared with the other forces, are formed when the cationic nucleus of a molecule is attracted to the electron cloud of another molecule, or vice versa. It results from transient alterations of polarisation in the nucleus affecting the surrounding dipole-dipole interactions and the nearby electron distribution. The weak van der Waals are complemented with the presence of large numbers of bindings arising from good electrostatic and steric interactions between both molecules ([@ref-11]).

The Lipinski's Rule of Five, also known as the Pfizer's Rule of Five by Christopher A. Lipinski explains the basic criteria which one compound needs to possess to exhibit druglikeness properties. Compounds which fulfil the following requirements are most likely to be membrane permeable and have high bioavailability following oral administration--molecular weight less than 500 g/mol, Log P less than five, less than 5 H-bond donors, less than 10 H-bond acceptors and molar refractivity in the range of 40--130 ([@ref-31]). As shown in [Table 9](#table-9){ref-type="table"}, the hesperetin molecule used in our study matches all five of the Lipinski's Rule of Five--molecular weight of 302 g/mol, Log P of 2.5, 3 H-bond donors, 6 H-bond acceptors and molar refractivity of 76.75. We compared our findings with the available data from PubChem to ensure that the ligand designed is reliable for our docking experiment. The results suggest that hesperetin has the necessary properties to be developed into an effective oral therapeutic for CHIKV infections. Furthermore, the non-structural proteins (3GPG and 3TRK) in complexed with hesperetin remained stable throughout the 10 ns MD simulations. In all, these findings are of utmost importance for determining whether hesperetin has the potential to be developed into an effective antiviral drug against CHIKV infections as well as its highest possible target protein.

Conclusion
==========

Hesperetin possesses interactions with all four CHIKV non-structural proteins in addition to SPK2 which plays a role in the virus replication cycle. These findings enhance our understandings on the possible underlying inhibitory mechanism of CHIKV replication, hence allowing further studies on these target proteins for the development of novel anti-CHIKV drug.

Supplemental Information
========================
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###### Trajectory files of Molecular Dynamics simulation of hesperetin with 3TRK and 3GPG for 10 ns.

The proteins are shown in cartoon representation and colored by secondary structure elements whereas hesperetin is shown in stick representation together with all the hydrogen atoms. The water molecules were hidden for the purpose of clarity.

###### 

Click here for additional data file.
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###### Hesperetin Molecular Docking Raw Data.

Docking conformations of hesperetin with varying binding affinities against different proteins of interest.

###### 

Click here for additional data file.
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